
On May 17, 2026, the EU’s Medical Device Carbon Footprint Disclosure Regulation (EU 2025/2198) entered into force in Germany, France, and the Netherlands — marking the first mandatory carbon footprint reporting requirement for large medical imaging equipment entering key EU markets. This development directly affects manufacturers of CT, MRI, and PET-CT systems, especially those exporting from China, and signals a structural shift in compliance expectations across global medtech supply chains.
The EU regulation EU 2025/2198 came into effect on May 17, 2026. It requires CT, MRI, and PET-CT devices placed on the market in Germany, France, and the Netherlands to be accompanied by a verified Life Cycle Assessment (LCA) report compliant with EN 15804+A2. Within the first week of implementation, three Chinese imaging equipment manufacturers — United Imaging, Neusoft, and Anke — completed third-party LCA verification. However, their average delivery lead times extended by two to three weeks, indicating immediate operational impact tied to data collection and verification requirements.
Manufacturers exporting CT, MRI, or PET-CT systems to Germany, France, or the Netherlands are now required to submit EN 15804+A2–compliant LCA reports prior to customs clearance or market placement. Non-compliance may delay registration, restrict market access, or trigger post-market scrutiny. The observed 2–3 week delivery extension reflects added time needed for documentation preparation, supplier data aggregation, and external verification — not just certification itself.
Suppliers providing critical subsystems (e.g., gantry assemblies, detector modules, cooling units) or raw materials (e.g., rare-earth magnets, copper, aluminum alloys) to imaging OEMs are indirectly affected. Under EN 15804+A2, upstream environmental data — including energy sources, transport modes, and material origin — must be traceable and verifiable. Suppliers lacking digitalized environmental data records or standardized EPD (Environmental Product Declaration) formats may become bottlenecks in OEMs’ LCA workflows.
Firms engaged in final assembly, integration, or testing of imaging systems — particularly those operating across multiple jurisdictions — face new data governance obligations. The regulation applies regardless of where manufacturing occurs; therefore, facilities outside the EU must support LCA data collection (e.g., site-specific energy consumption, waste treatment methods, packaging materials). Inconsistent internal measurement practices or lack of ISO 14040/44-aligned procedures may delay verification timelines.
Third-party LCA verifiers, EPD program operators, and regulatory consultants experienced in EN 15804+A2 are seeing increased demand — particularly from Asian OEMs unfamiliar with construction-sector–derived LCA standards applied to medical devices. Limited verifier capacity in certain regions has contributed to the reported delivery delays, suggesting potential service constraints in near-term implementation.
While EU 2025/2198 is in force, national interpretations — especially regarding transitional arrangements, acceptable data sources for legacy components, and verification scope boundaries — remain under clarification. Germany’s BfArM and the EU Commission’s MDCG are expected to issue non-binding guidance documents in Q3 2026; these should be tracked closely for operational implications.
Not all models require immediate submission — only those newly placed on the market in covered countries after May 17, 2026. Companies should identify top-selling CT/MRI variants destined for Germany, France, and the Netherlands, and allocate verification resources accordingly. Retrospective LCA for existing registered models is not mandated at this stage.
The current delivery delays reflect procedural adaptation, not formal penalties. No enforcement actions or fines have been publicly reported in the first week. Analysis shows that the regulation functions initially as a gatekeeping mechanism rather than a punitive tool — meaning process maturity, not legal risk, is the dominant near-term concern.
OEMs should begin sharing standardized data request forms — aligned with EN 15804+A2’s Module A1–A5 structure — with Tier 1 suppliers. Early alignment reduces iteration cycles during LCA drafting. Pilot requests can focus on five high-impact materials or subassemblies (e.g., power supplies, shielding, collimators) to test responsiveness and data quality.
Observably, this regulation marks the first instance where carbon accounting requirements — previously concentrated in construction and electronics — are formally extended to regulated medical devices in the EU. From an industry perspective, it is less a sudden disruption and more a crystallization of longer-term trends: growing regulatory convergence around product-level environmental transparency, and the increasing use of construction-sector LCA frameworks (EN 15804) in non-building sectors. Current evidence suggests the rule is functioning primarily as a market access filter rather than a compliance enforcement regime — but its scalability to other EU member states (e.g., Italy, Spain) and future revision cycles (e.g., inclusion of Scope 3 upstream emissions thresholds) warrants ongoing attention.
Conclusion
This regulation does not introduce new environmental performance limits — only disclosure and verification obligations. Its significance lies in institutionalizing lifecycle carbon data as a prerequisite for trade, thereby elevating data infrastructure, supplier collaboration, and cross-functional compliance literacy from operational support functions to core export capabilities. For now, it is more accurately understood as a procedural threshold than a technical standard — one that rewards preparedness over perfection, and transparency over optimization.
Information Sources
Note: Implementation details for non-pilot EU member states, enforcement timelines beyond Q3 2026, and potential revisions to Annex II (product scope) remain subject to ongoing monitoring.
Related News
Related News
0000-00
0000-00
0000-00
0000-00
0000-00
Weekly Insights
Stay ahead with our curated technology reports delivered every Monday.